The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Actemra is an injectable medication used to alleviate chronic inflammation in patients suffering from rheumatoid arthritis or Giant Cell Arteritis. Genentech, part of the Roche Group, manufactured and marketed the drug, which was approved by the Federal Drug Administration (FDA) for use in 2010. Following its release onto the market, studies have reported the deaths of over 1,000 Actemra patients, with more than 13,000 experiencing adverse side effects not included in the warning labels of the medication. Of those patients who passed away, hundreds were found to have died of heart failure. Other severe side effects that have been linked to Actemra include:



Interstitial lung disease


Even before Actemra’s approval, in 2009, an international study raised concerns regarding the adverse side effects and fatality risks associated with the medication. If you have suffered a serious side effect, such as a heart attack, stroke, or pancreatitis, after taking Actemra, you may be able to pursue legal action against the parties responsible for your injuries. If a loved one has died as a result of complications related to Actemra use, certain family members may be entitled to compensation in a wrongful death action. A STAT investigation found that the risks of Actemra, a rheumatoid arthritis drug, might be greater than patients are led to believe.

If you or a loved one has been hurt due to an Actemra side effect, please contact Jamie Sheller Esq. for a free consultation at 1800 883 2299.


Comments are closed.